Former CEO of Navire Pharma and CoA Therapeutics to lead digital biology company’s pharmaceutical business and clinical development, including its newly formed Development Corporation SALT LAKE CITY--( BUSINESS WIRE )-- Recursion , a digital biology company industrializing drug discovery, today announced the appointment of Shafique Virani, M.D., as its Chief Corporate Development Officer. In this role, Dr. Virani will serve as both Recursion’s Chief
March 17, 2020
· 4 min read